A
Abhay A. Shukla
Associate Professor
faculty
Pediatrics, College of Medicine
14 h-index
54 pubs
714 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Abhay A. Shukla investigates mechanisms of disease, focusing on inflammation, oxidative stress, and metabolic disorders in various patient cohorts. His recent work includes studies on germ cell tumors, dry eye disease, Sjogren's syndrome, and complete heart block, exploring associated systemic markers and cellular processes. Shukla also examines the impact of intrauterine growth restriction on infant brain development using magnetoencephalography and investigates rare genetic conditions, such as biallelic δ-Aminolevulinic Acid Dehydratase mutations in newborns.
His research has been supported by grants, and he has published extensively, with a h-index of 12 and over 700 citations. Shukla collaborates with researchers at the University of Arkansas for Medical Sciences, including Ankita Shukla, with whom he shares five co-authored publications. His recent publications span from 2023 to 2025, indicating ongoing activity in his research areas.
Metrics
- h-index: 14
- Publications: 54
- Citations: 714
Selected Publications
-
Changes in the Pediatric–Adult Academic Subspecialists Compensation Gap (2026)
-
Fetal Magnetoencephalographic Power Spectral Density and Neurobehavioral Correlation in Intrauterine Growth Restriction (IUGR) (2026)
-
453 PERFORM: Persistent effects of intrauterine growth restriction (IUGR) on infant brain development: A comparative magnetoencephalography (MEG) study (2025)
-
Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2025)
-
Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2024)
-
04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations (2024)
-
Preterm Infant with Persistent Hypercalcemia in the Absence of Cutaneous Nodules (2022)
-
In the grey zone—survival and morbidities of periviable births (2022)
Grants & Funding
- Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia (SILDI-SAFE) (IRB 275107) NIH/Nat. Heart, Lung & Blood Institute - Pass Through: Duke University Principal Investigator
- Magnetoencephalography based tracking of fetal neurodevelopment in diabetic pregnancies NIH/Nat. Inst. of Child Health & Human Development Co-Investigator
Collaboration Network
Top Collaborators
James F. Amatruda
9 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Showing 5 of 9 shared publications
Kenneth Chen
5 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Nicholas J. Fustino
5 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Sarai H. Stuart
5 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Leendert H. J. Looijenga
5 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Dinesh Rakheja
5 shared publications
- Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Daniel Verduzco
4 shared publications
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
Jennifer Shepard Dovey
4 shared publications
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
Elisabeth Kodym
4 shared publications
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
Brian Skaug
4 shared publications
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Supplementary Figures 1-10 from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
- Data from Multiple Isoforms of CDC25 Oppose ATM Activity to Maintain Cell Proliferation during Vertebrate Development
Emily K. Stroup
4 shared publications
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Albert Budhipramono
4 shared publications
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Christina Ateek
4 shared publications
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Kiyoshi Yamaguchi
4 shared publications
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Payal Kapur
4 shared publications
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Supplementary Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
- Data from EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors
Similar Researchers
Based on overlapping research topics
Matthew R. Savage
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Metabolism and Genetic Disorders
Disease Mechanisms Research
Anna Blackshare
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Disease Mechanisms Research
Child and Adolescent Health
Ankita Shukla
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Metabolism and Genetic Disorders
Disease Mechanisms Research
Supriya Jambhekar
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Metabolism and Genetic Disorders
Disease Mechanisms Research
Kirt E. Simmons
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Disease Mechanisms Research
Child and Adolescent Health
Hannah Campbell
University of Central Arkansas
Immune Response and Inflammation
Metabolism and Genetic Disorders
Disease Mechanisms Research